source
- Roche to acquire digital pathology firm PathAI in deal potentially worth over $1BRoche plans to offer PathAI’s tools as part of an effort to improve cancer diagnosis and tailored treatment.BioPharma Dive · 3mo ago↗ source
- STAT+: More political interference at the FDA?A political appointee gets in the way of a Sanofi drug's approval, and more from STAT's D.C. Diagnosis newsletter.STAT · 3mo ago↗ source
- STAT+: Pharmalittle: We’re reading about Sanofi and an FDA voucher, FDA rethinking a rejection, and moreSanofi asked the FDA to pull teplizumab out of a speedy review voucher program after a political appointee disagreed with staff over its approvalSTAT · 3mo ago↗ source